Remove profiles quest-diagnostics
article thumbnail

Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health

3BL Media

January 29, 2024 /3BL/ - Fitbit and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, recently announced a collaboration to study the potential of wearable devices to improve metabolic health, which influences risk of developing several diseases, including diabetes and heart disease.

Analytics 147
article thumbnail

Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis

3BL Media

December 19, 2023 /3BL/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Scipher Medicine, a precision immunology company, recently announced a multi-pronged collaboration designed to expand patient access to diagnostic services advancing precision medicine for rheumatoid arthritis (RA).

Logistics 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

First PFAS “Forever Chemicals” Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com

3BL Media

March 4, 2024 /3BL/ - Quest Diagnostics (NYSE: DGX), the world's leader in diagnostic information services, announced the availability of the first consumer-initiated, physician-ordered blood-draw test for PFAS chemicals with the option to confer over the phone with a physician about the results. for a blood draw*.

article thumbnail

Expanding Healthcare Access and Affordability at Quest Diagnostics

3BL Media

Originally published in Quest Diagnostics Corporate Responsibility Report 2022 Empowering consumers with direct health insights In October 2022, we launched questhealth.com to better deliver actionable diagnostic insights directly to health-minded consumers without first requiring a doctor’s visit.

article thumbnail

High Rates of Chronic Hepatitis B and Tuberculosis Co-Infection Observed in Nationally Representative Quest Diagnostics Study

3BL Media

SOURCE: Quest Diagnostics. The study was conducted by researchers from Quest Diagnostics (NYSE: DGX), Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System in Palo Alto, Calif. Senior Medical Director and Director of the Health Trends research program for Quest Diagnostics. "It

article thumbnail

Hispanic Scholars Receive Financial Support for STEM Studies and Research

3BL Media

The American Heart Association Hispanic Serving Institutions Scholars program supports priority diversification in the pipeline of healthcare professionals with the support of the Quest Diagnostics. SOURCE: Quest Diagnostics. KEYWORDS: NYSE:DGX, Quest Diagnostics.

Academics 130
article thumbnail

Developing and Retaining Talent at Quest Diagnostics

3BL Media

Originally published in Quest Diagnostics Corporate Responsibility Report 2022 2022 highlights Quest employees completed over 1 million hours of training, an average of over 24 hours per full-time employee Nearly 1,000 employees received tuition reimbursement totaling $3.3